Articles tagged with Cancer Treatments
Researchers have identified new biomarkers that correlate with patient response to anti-TNFá therapy, improving the treatment of spondylarthritis. The study found changes in synovial tissue features, such as macrophage and PMN cell changes, associated with disease activity and treatment effectiveness.
Researchers at Stanford University School of Medicine have made significant progress in developing RNAi gene therapy, a promising approach to treating organ-wide diseases. However, they also encountered unexpected side effects, including liver toxicity in mice, which hindered their progress. Despite this setback, the team was able to o...
Researchers found that men with the same hemoglobin levels before treatment experienced significantly different overall and progression-free survival depending on whether they were black or white. Anemic blacks fare worse than anemic whites, while blacks with high baseline hemoglobin fare better.
Research presented at Digestive Disease Week 2006 highlights current trends and advancements in GI cancers, clinical studies, and lifestyle choices. The meeting showcases more than 5,000 abstracts on the latest advances in GI research, medicine, and technology.
Researchers found that women who gained more than 60 pounds during adulthood were almost twice as likely to have ductal type tumors and more than 1.5 times more likely to have lobular type cancers. The risk for metastatic disease increased with weight gain, particularly among those who gained over 60 pounds.
Researchers at Stanford University have uncovered a novel mechanism of the tumor suppressor ING2, which regulates gene expression programs to prevent cancer formation. The findings highlight a new approach to understanding DNA damage responses in normal cells and potential therapeutic targets for cancer prevention and treatment.
A new study from the University of Michigan finds that patients often struggle to access reliable medical information online. Librarians play a crucial role in helping patients find quality resources, providing expertise and accessing specialized databases not available to the general public.
A new professorship in melanoma research has been established at the Cross Cancer Institute in Edmonton, Alberta. The endowment fund, valued at $1 million, will support long-term commitment to researching key pathways in melanoma development that could lead to potential targets for prevention and therapy.
A study of 403 premenopausal women with estrogen receptor-positive breast cancer found that increased Pak1 expression correlates with reduced sensitivity to tamoxifen therapy, leading to decreased survival rates. Researchers suggest targeting Pak1 as a potential strategy to improve treatment response in breast cancer.
In-vivo gene therapy has successfully restored immune function in three out of four dogs treated for XSCID. The treatment approach eliminates the need for ex-vivo cell manipulation and culture, potentially reducing adverse side effects and improving long-term efficacy.
Researchers discovered a novel compound, PI-103, that cooperatively inhibits both p110α subunit of PI3 kinase and downstream molecule mTOR. This dual inhibition shows high effectiveness against human gliomas in mice without toxicity.
Researchers have developed a completely penetrant mouse model of head and neck squamous cell carcinoma, recapitulating the human disease at both pathological and molecular levels. The model enables testing of combinations of targeted therapies and prevention approaches for HNSCC.
Researchers have discovered that C-myc, known as an oncogene, acts downstream of IL-15 signaling to regulate T memory cell homeostasis. This finding has implications for future therapies and highlights the importance of preserving a gene's role in normal processes.
A new study by Fox Chase Cancer Center reveals specific defects in RNA translation underlie a progressive disease called dyskeratosis congenita, linked to anemia, immune deficiency, cancer, and premature aging. The research highlights the importance of proteomic analysis and potential therapeutic targets for developing treatments.
Researchers found that follow-up PET scans showed persistent tumor activity in seven out of eleven RFA treatments. This suggests that FDG-PET is a more accurate method for evaluating tumor destruction than CT alone.
A recent mouse study led by the Salk Institute has discovered that healthy copies of the IL2RG gene used in X-linked severe combined immune deficiency (X-SCID) gene therapy can promote cancer development. One-third of mice treated with the gene developed lymphoma later in life.
A study of 797 breast cancer survivors found that only 33% received a mammogram each year over the five years after treatment. Regular mammography for breast cancer survivors declines steadily within five years of treatment, highlighting the need to increase awareness among healthcare providers and patients.
A national survey of 954 adults found that 44.7% of African-Americans and 33.5% of whites reported low trust in healthcare providers. Understanding these differences can help physicians improve trust and medical care for diverse patient communities.
Researchers have made progress toward a new form of light-activated gene therapy for cartilage repair, which is safe and compatible with existing surgical techniques. The therapy uses UV light to target specific cells and promote tissue growth, offering hope for treating knee injuries and potentially other conditions.
Researchers identified an intrinsic pathway involving PTEN that regulates stem cell transitions between quiescence and activity. Disrupting PTEN leads to increased active cycling and loss of quiescent stem cells, hindering long-term maintenance.
Researchers have found cancer cells suppress entire chromosome bands through epigenetic changes, silencing genes that prevent tumor growth. The discovery could lead to new treatments targeting DNA demethylation.
Researchers discover the structure of the WRN exonuclease domain, revealing its role in repairing DNA damage and maintaining genomic integrity. The study sheds light on the mechanisms underlying Werner's syndrome, a rare inherited disease that accelerates aging.
A study of over 39,000 women found that hormone therapy reduced the risk of heart attacks by 32% for those starting treatment in their 50s. However, the risk increased in older women within the first year of treatment before it decreased after two years.
A study of 25,719 women found that five-year cancer survivors reported functional limitations, such as heavy household work and mobility issues. The authors highlight the need for interventions to prevent and reverse functional decline among elderly long-term cancer survivors.
Scientists have successfully reversed cell division, a process essential to life, and may use this discovery to control cancer development and metastasis. The research holds promise for preventing and treating birth defects and other conditions.
Researchers found that combining a PI3K inhibitor with Herceptin can reverse lack of response in HER2-positive breast cancer patients. The addition of a PI3K inhibitor showed significant benefit in halting tumor growth, especially in tumors lacking PTEN protein.
Researchers found that omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) inhibited the growth of liver cancer cells, whereas omega-6 fatty acid arachidonic acid (AA) had no effect. The compounds induced apoptosis and decreased beta-catenin levels, which are involved in tumor progression.
Dasatinib has shown promise in treating leukemia patients resistant to standard therapies, with 93% complete hematologic response and 45% major cytogenetic response. However, relapses have occurred in certain patient groups due to dasatinib-resistant BCR-ABL mutations.
Researchers report three cases of advanced cancers with long survival times after high-dose intravenous vitamin C therapy. The study suggests that high-dose intravenous vitamin C should be reassessed as a potential cancer treatment option.
Research reveals that men's concerns about controlling their cancer drive treatment choices, despite limited reliance on scientific evidence. The study highlights the need for improved patient education and informed decision-making support.
A study by U-M researchers found that patients with delayed surgery (more than 93 days) had worse survival rates and lower three-year survival rates compared to those with timely surgery. Scheduling issues were the most common cause of delay, which can lead to micrometastases and poor outcomes.
A new study found that weight training significantly improved the quality of life for breast cancer survivors, reducing symptoms such as depression and anxiety. The exercise program also increased lean body mass and upper body strength.
The European School of Oncology task force recommends a multidisciplinary approach to managing metastatic breast cancer, prioritizing patient psychological wellbeing and disease-specific treatment goals. Patients with MBC should be offered psychosocial support and involved in decision-making.
A breakthrough project in the Netherlands dramatically improved patient care for breast cancer patients by implementing structured best practices. The initiative reduced waiting times to under a week and increased pre-operative multidisciplinary consultations, leading to more clear-cut diagnoses and fewer unnecessary operations.
Tadatsugu Taniguchi is honored with the international award for his major scientific discovery in basic cancer research, elucidating cytokine gene families and transcription factors. He made significant contributions to our understanding of immune defense mechanisms and cancer therapy.
The UK Biobank project is a revolutionary research undertaking that will gather and store vast amounts of medical data from 40,000 to 69-year-old volunteers. Researchers hope to identify more reliable reasons for why some people develop specific diseases and others do not.
A study identifies molecular subclasses of high-grade gliomas that correlate with disease progression and prognosis. The subtypes resemble stages in neurogenesis, suggesting new insights for therapeutic intervention.
Researchers found that Aldara Cream reduced fine lines and wrinkles, improved skin texture, and enhanced color in prematurely aged skin. The cream showed significant improvements in 80% of the subjects, with 90% expressing strong approval.
The Australian government has pledged $50 million to support the expansion of the Walter and Eliza Hall Institute's (WEHI) research capabilities in cancer and infectious disease. This funding will enable significant expansions in the institute's research programs, focusing on targeted therapies for cancer treatment and malaria control.
A study found that internet use increases feelings of control among cancer patients, allowing them to view their relationship with doctors as a partnership. Online access also enables patients to make informed decisions about their treatment.
A study suggests that delayed surgical intervention can be a safe alternative to immediate treatment for men diagnosed with early-stage, low-grade prostate cancer. The research found equivalent risks of noncurable prostate cancer in both groups, depending on factors like age and PSA levels.
A study by the North Central Cancer Treatment Group found that reducing epoetin alfa dosing frequency from once weekly to every three weeks did not significantly impact hemoglobin levels or require transfusions. Patients in both treatment groups reported similar quality of life at the end of the 21-week study.
Researchers found a substantial link between severe rheumatoid arthritis and increased risk of lymphoma. Patients with high RA activity experienced a 70-fold increase in lymphoma risk, while those with low activity had an 8-fold increase.
Experts warn that sharing study results with participants could negatively impact their future health due to potential regret over less effective treatments. A revised informed consent strategy is proposed to balance individual rights with the need for transparency.
Researchers found that a common osteoporosis treatment helped men with prostate cancer recover significant bone mass after two years of androgen deprivation therapy. The study suggests that bone density tests should be encouraged for men at risk, and bone-preserving therapy could prevent debilitating fractures.
A recent study by Dr. Elizabeth Krall Kaye found that cigarette smokers are 70% more likely to need root canal treatment than nonsmokers. Quitting smoking is linked to a lower risk of needing the procedure.
A six-week program combining a nicotine patch and group support significantly increased the chances of women in public housing quitting smoking. The study found nearly 50% of women in the treatment group quit smoking by the end of the program, compared to less than 8% in the comparison group.
Kereos is developing a nanotechnology program to diagnose and treat cancer, detecting solid tumors as small as 1-2 mm. The technology can deliver high concentrations of chemotherapeutic agents to tumors with low standard doses.
A population-based case-control study found that women using medium potency estrogen-progestin combination therapy had a higher risk of developing lobular or tubular breast cancer. The risk was more pronounced for those who used the therapy for over five years, with a notable increase in the incidence of tubular and lobular cancers.
Researchers have identified the stage-specific roles of individual cathepsins in tumorigenesis, revealing that inhibiting cathepsin B, L, and S suppresses cancer development. The study found that these cathepsins promote tumor invasion by cleaving E-cadherin.
A study of 61,228 men aged 65 and older with local or regional stage prostate cancer found that lower socioeconomic status was significantly associated with decreased survival. Socioeconomic factors, including education level and community poverty, were the primary drivers of disparities in survival.
A blood test measuring NT-proBNP levels can accurately predict one-year mortality risk in patients with shortness of breath, regardless of underlying heart failure diagnosis. The study suggests that this test should be routinely used to identify high-risk patients needing more intensive treatment and follow-up.
Researchers found that excisional treatments, such as cold knife conisation and Large Loop Excision of the Transformation Zone (LLETZ), are associated with a small but real increase in risk of pregnancy-related morbidity. The findings suggest that cervical screening after the age of 25 may be beneficial for long-term obstetric outcomes.
Researchers at Florida State University have discovered a molecular mechanism that inhibits HCV replication in vitro after host cells become crowded. The study's new test can quickly monitor HCV replication and has the potential to lead to better, targeted treatments for this complex virus.
A recent study suggests that lung cancer survival rates may be tied to access to standard cancer care, rather than racial disparities. Researchers analyzed data from 995 patients with advanced small cell lung cancer and found that equal treatment yielded the same outcomes for black and non-black patients, regardless of stage or ethnicity.
Researchers have alleviated symptoms of Rett syndrome in mice by hyper-expressing the BDNF gene, which showed a drastic reduction in lethargy and improved cortical neuron activity. The findings may lead to potential therapeutic strategies for treating the condition.
The five-year data demonstrate long-term efficacy and reliability of MAL-PDT for treating superficial and nodular basal cell carcinomas, with superior cosmesis compared to cryotherapy. The treatment was found to be non-inferior to surgery in relation to initial response rates, but with significantly better cosmetic outcomes.
A common molecular signature of miRNA expression has been identified in solid tumors, providing insight into gene regulation and potential new approaches for diagnosis and treatment. This finding confirms the importance of microRNAs in growth and survival across species.
Researchers at the University of Nevada and Los Alamos National Laboratory have developed a breakthrough in concentrating carbon ion beams, a crucial step towards improving cancer tumor treatment. The innovation also opens up opportunities for advances in nuclear fusion applications.
The Tumor-Host Genomics project aims to understand the molecular and cellular interactions between tumor cells and their microenvironment. By developing advanced functional genomics instruments and technologies, researchers hope to identify new targets for anti-cancer therapy.